On the court and in the field of play, the risk for sports-related eye injuries is prevalent. Knowing how to properly treat the injuries as well as wearing the proper gear may not only reduce the severity of the injury, but also may prevent eye injury….
Glaukos Corporation Announces Third Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Aerie Pharmaceuticals Reports Third Quarter 2019 Financial Results, Updates Full-Year 2019 Guidance and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
VIDEO: Combining IC-8 with bifocal refractive multifocal lenses
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Gerd Auffarth, MD, PhD, FEBO, discusses his poster presentation on the combined use of the IC-8 IOL (AcuFocus) and a bifocal refractive multifocal lens.
Optical Nanoprobes Monitor Neural, Cardiac Cell Activity
Monitoring neurons and other excitable cells in vivo for research and clinical applications has usually required the use of electrode arrays. These are quite limited in their electrode density and the area that they can cover. Moreover, the amount of signal generated by the neurological system overwhelms any attempts at building large scale electro (Read more...)
Expert discusses anti-inflammatory agents for atopic, vernal conjunctivitis
SAN FRANCISCO — Stephen Pflugfelder, MD, professor and James and Margaret Elkins Chair in Ophthalmology at Baylor College of Medicine, discussed using topical anti-inflammatory agents to manage atopic and vernal conjunctivitis in a presentation at Corn…